Taylor Wealth Management Partners’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $296K | Sell |
4,514
-851
| -16% | -$55.8K | 0.17% | 49 |
|
|
2022
Q1 | $357K | Buy |
5,365
+50
| +0.9% | +$3.33K | 0.14% | 53 |
|
|
2021
Q4 | $372K | Sell |
5,315
-1,300
| -20% | -$91K | 0.13% | 51 |
|
|
2021
Q3 | $345K | Hold |
6,615
| – | – | 0.12% | 57 |
|
|
2021
Q2 | $450K | Buy |
6,615
+200
| +3% | +$13.6K | 0.16% | 51 |
|
|
2021
Q1 | $494K | Buy |
6,415
+637
| +11% | +$49.1K | 0.18% | 57 |
|
|
2020
Q4 | $347K | Buy |
+5,778
| New | +$347K | 0.13% | 51 |
|